From Comparative Pathogenesis to Biomarker-guided Treatments in Psoriasis and Eczema

At ESDR 2024 | September 4, 2024 | Time: 13:00-17:00 (1:00-5:00 PM WEST | local time) 

Lisbon Congress Center | Praça das Indústrias,1300-307 | Lisbon, Portugal

A joint program of the IEC and International Psoriasis Council (IPC).

REGISTER TODAY

PROGRAM CHAIRS

AGENDA 

13:00-13:10 Welcome and introduction
Johann Gudjonsson, MD, PhD | University of Michigan, Ann Arbor, Michigan, United States
Nick Reynolds, BSc, MBBS, MD, FRCP | IEC Councilor | Newcastle University, Newcastle upon Tyne, United Kingdom

13:10-13:30 The Comparative Pathogenesis of Psoriasis and Atopic Dermatitis 
Speaker TBA

13:30-13:50 Phenotype Switching 
Speaker TBA

13:50-14:10 Genetic and Ethnic Differences in Psoriasis and Atopic Dermatitis
Sara Brown, MBChB, MD | IEC Councilor | University of Edinburgh, Edinburgh, Scotland, United Kingdom

14:10-14:25 Panel Discussion | All Faculty

14:25-14:40 BREAK

14:40-15:25 Abstract Presentations
Abstract Speakers TBA

15:25-15:45 Using Biomarkers to Inform the Treatment of Atopic Dermatitis
Marjolein de Bruin Weller, MD, PhD | IEC Councilor | Utrecht University, Utrecht, Netherlands

15:45-16:05 Using Biomarkers to Inform the Treatment of Psoriasis
Speaker TBD

16:05-16:25 Using Biomarkers to Assess the Risk of Comorbidities
Christian Vestergaard, MD, PhD, DMSc | IEC Councilor | Aarhus University, Aarhus,

16:25-16:45 Using Biomarkers to Assess the Risk of Comorbidities
Catherine Smith, MD | St John’s Institute of Dermatology, Guys and St Thomas’ Hospitals, London, United Kingdom

16:45-17:00 Panel Discussion | All Faculty

17:00 Closing Comments & Adjourn
Akimichi Morita, MD, PhD | Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
Tiago Torres, MD, PhD | IEC Councilor | University of Porto, Porto, Portugal

Please check back for updates.  

This educational symposium presented by the IEC is offered at no cost to attendees.

HEALTH AND SAFETY TRAVEL RESOURCES

IEC and IPC will comply with local mandates at the time of the in-person meeting.